HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Brian W Pogue Selected Research

Verteporfin (Visudyne)

1/2020Multispectral singlet oxygen and photosensitizer luminescence dosimeter for continuous photodynamic therapy dose assessment during treatment.
4/2019Elastography Can Map the Local Inverse Relationship between Shear Modulus and Drug Delivery within the Pancreatic Ductal Adenocarcinoma Microenvironment.
6/2017Separation of Solid Stress From Interstitial Fluid Pressure in Pancreas Cancer Correlates With Collagen Area Fraction.
1/2017Collagen Complexity Spatially Defines Microregions of Total Tissue Pressure in Pancreatic Cancer.
5/2015Perfusion CT estimates photosensitizer uptake and biodistribution in a rabbit orthotopic pancreatic cancer model: a pilot study.
4/2014CT contrast predicts pancreatic cancer treatment response to verteporfin-based photodynamic therapy.
12/2013Contrast enhanced-magnetic resonance imaging as a surrogate to map verteporfin delivery in photodynamic therapy.
1/2010Imaging tumor variation in response to photodynamic therapy in pancreatic cancer xenograft models.
8/2008Disparity between prostate tumor interior versus peripheral vasculature in response to verteporfin-mediated vascular-targeting therapy.
9/2007Peptide-induced inflammatory increase in vascular permeability improves photosensitizer delivery and intersubject photodynamic treatment efficacy.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Brian W Pogue Research Topics

Disease

126Neoplasms (Cancer)
06/2022 - 01/2002
19Breast Neoplasms (Breast Cancer)
06/2022 - 01/2003
15Glioma (Gliomas)
11/2018 - 06/2008
8Adenocarcinoma
06/2020 - 02/2003
8Pancreatic Neoplasms (Pancreatic Cancer)
04/2019 - 01/2010
6Actinic Keratosis
12/2019 - 09/2010
5Brain Neoplasms (Brain Tumor)
09/2014 - 09/2006
4Margins of Excision
06/2022 - 03/2013
4Hypoxia (Hypoxemia)
06/2022 - 01/2020
4Necrosis
01/2021 - 01/2005
4Ductal Carcinoma
09/2017 - 01/2003
4Glioblastoma (Glioblastoma Multiforme)
01/2017 - 03/2011
3Residual Neoplasm
01/2021 - 11/2010
3Sarcoma (Soft Tissue Sarcoma)
06/2019 - 12/2017
3Skin Neoplasms (Skin Cancer)
03/2019 - 11/2013
3Neoplasm Metastasis (Metastasis)
01/2018 - 01/2005
3Pain (Aches)
01/2018 - 01/2014
3Pathologic Complete Response
10/2016 - 08/2009
3Ovarian Neoplasms (Ovarian Cancer)
09/2013 - 11/2010
2Head and Neck Neoplasms (Head and Neck Cancer)
01/2020 - 01/2020
2Melanoma (Melanoma, Malignant)
03/2019 - 06/2014
2Hypertension (High Blood Pressure)
06/2017 - 01/2017
2Phototoxic Dermatitis (Phototoxicity)
01/2017 - 07/2005
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2016 - 11/2015
2Fibrosarcoma
03/2003 - 02/2003
1Synovial Sarcoma (Synovioma)
12/2020
1Squamous Cell Carcinoma of Head and Neck
07/2020
1Pathologic Processes
01/2020
1Infections
01/2019
1AIDS-Related Complex (ARC)
06/2018

Drug/Important Bio-Agent (IBA)

301-phenyl-3,3-dimethyltriazene (PDT)IBA
11/2021 - 03/2003
24protoporphyrin IXIBA
06/2020 - 05/2002
19Hemoglobins (Hemoglobin)IBA
12/2021 - 01/2002
19Verteporfin (Visudyne)FDA Link
01/2020 - 05/2002
18ErbB Receptors (EGF Receptor)IBA
12/2020 - 06/2008
17Pharmaceutical PreparationsIBA
01/2021 - 10/2003
16Photosensitizing Agents (Photosensitizers)IBA
11/2021 - 05/2002
11Oxygen (Dioxygen)IBA
06/2022 - 05/2002
11Aminolevulinic Acid (Levulan)FDA Link
06/2020 - 05/2002
8CollagenIBA
01/2021 - 10/2005
7ABY-029IBA
12/2020 - 09/2016
6Coloring Agents (Dyes)IBA
01/2021 - 09/2010
6Epidermal Growth Factor (EGF)IBA
08/2012 - 03/2009
5Biological ProductsIBA
06/2022 - 04/2009
5LipidsIBA
07/2010 - 01/2002
4IRDye 800CWIBA
12/2020 - 12/2017
4Cetuximab (Erbitux)FDA Link
07/2020 - 01/2010
4AcidsIBA
12/2017 - 09/2010
4Proteins (Proteins, Gene)FDA Link
07/2015 - 01/2005
4Fluorescent Dyes (Fluorescent Probes)IBA
01/2013 - 06/2008
3Biomarkers (Surrogate Marker)IBA
01/2019 - 06/2012
3Hyaluronic Acid (Hyaluronan)IBA
12/2017 - 01/2017
3GadoliniumIBA
10/2017 - 09/2011
3Contrast MediaIBA
10/2017 - 01/2009
3Cell Surface ReceptorsIBA
07/2015 - 05/2013
2Eosine Yellowish-(YS) (Eosin)IBA
01/2021 - 09/2011
2aluminum phthalocyanineIBA
01/2020 - 02/2003
2thiamine triphosphorate (TTP)IBA
06/2017 - 01/2017
2Peptides (Polypeptides)IBA
01/2017 - 01/2013
2Deferoxamine (Desferal)FDA LinkGeneric
01/2016 - 03/2010
2Vitamin DFDA LinkGeneric
11/2015 - 09/2012
2salicylhydroxamic acid (SHAM)IBA
04/2015 - 03/2010
2Green Fluorescent ProteinsIBA
01/2013 - 09/2011
2Membrane Proteins (Integral Membrane Proteins)IBA
07/2012 - 01/2006
2deoxyhemoglobinIBA
05/2011 - 08/2009
1Complement System Proteins (Complement)IBA
06/2022
1Indicators and Reagents (Reagents)IBA
12/2021
1Dextrans (Dextran)FDA Link
01/2021
1rhodamine BIBA
01/2021
1Texas redIBA
01/2021
1Indocyanine Green (Cardio-Green)FDA LinkGeneric
12/2020
1Sepharose (Agarose)IBA
11/2020
1NanoconjugatesIBA
07/2020
1transcobalamin receptorIBA
06/2020
1Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric
06/2020
1aluminum tetrasulfophthalocyanineIBA
01/2020
1tetrasulfophthalocyanineIBA
01/2020
1Singlet OxygenIBA
01/2020
1AluminumIBA
01/2020
1MetalsIBA
01/2018
1Irinotecan (Camptosar)FDA LinkGeneric
01/2018

Therapy/Procedure

29Photochemotherapy (Photodynamic Therapy)
01/2021 - 05/2002
23Therapeutics
03/2021 - 01/2005
11Neoadjuvant Therapy
10/2016 - 06/2008
10Radiotherapy
06/2022 - 02/2012
9Segmental Mastectomy (Lumpectomy)
06/2022 - 01/2013
4Lasers (Laser)
01/2020 - 01/2005
3Drug Therapy (Chemotherapy)
10/2020 - 11/2010
2Precision Medicine
06/2020 - 01/2012
2Particle Accelerators
01/2020 - 06/2018
2Radiation Dosimeters
01/2020 - 01/2014
2Intravenous Injections
04/2019 - 01/2017
2Aftercare (After-Treatment)
08/2008 - 03/2003
1Chemoradiotherapy
10/2020
1Phototherapy (Light Therapy)
06/2020
1Tattooing
01/2020
1Debridement
01/2019
1Catheters
06/2017
1Injections
09/2016
1Craniotomy
03/2016